Procurement Summary
Country: Poland
Summary: Delivery of Medicinal Products
Deadline: 07 Sep 2026
Posting Date: 06 Aug 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 146656895
Document Ref. No.: 545797-2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33690000 - Various medicinal products
33651100 - Antibacterials for systemic use
33652100 - Antineoplastic agents
33610000 - Medicinal products for the alimentary tract and metabolism
33696000 - Reagents and contrast media
33621100 - Antithrombotic agents
33670000 - Medicinal products for the respiratory system
33661000 - Medicinal products for the nervous system
33622000 - Medicinal products for the cardiovascular system
33662100 - Ophthalmologicals
33642000 - Systemic hormonal preparations, excl. sex hormones
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Part 1 - Miscellaneous medicines Part 2 - Drugs for infections I Part 3 - Apomorphine Part 4 - Calcium chloratum Part 5 - Ramucirumabum Part 6 - Drugs used in infections II Part 7 - Aflibercept Part 8 - Ozanimod Part 9 - Palopegteriparatidum Part 10 - Ceftriaxone Part 11 - Infliximabum Part 12 - Parenteral and enteral nutrition Part 13 - Pazopanib Part 14 - Enteral nutrition preparations Part 15 - Iodixanolum Part 16 - Enoxaparin Part 17 - Omalizumab Part 18 - Parenteral nutrition Part 19 - Allergens Part 20 - Cabozantinibum Part 21 - Propofolum Part 22 - Paracetamol Part 23 - Central nervous system Part 24 - Cardiovascular system Part 25 - Temozolamide Part 26 - Ornithine Part 27 - Afliberceptum Part 28 - Fluids Part 29 - Lidocainum Part 30 - Dexmedetomidine Part 31 - Somatostatin Part 32 - Darolutamide Part 33 - Ondansetron Part 34 - The digestive tract and metabolism Part 35 - Eye medications Part 36 - Osimertinib Part 37 - Dostarlimabum Part 38 - Trastuzumab Part 39 - Aciclovir Part 40 - Vedolizumab Part 41 - Respiratory system Part 42 - Capivasertibum Part 43 - Levodopum + Carbidopum + Entacaponum Part 44 - Rozanolixizumabum Part 45 - Adagrasibum Part 46 - Guselkumabum Part 47 - Berotralstatum Part 48 - Lanadelumabum Part 49 - C1 - esterase inhibitor Delivery of medicinal products divided into 49 parts Part 1 - Miscellaneous drugs - quantitative specification...
Document Type: Contract Notice Reference Number: DZP.281.60A.2026 Contract Type: supplies Authority Type: body-pl Doc Title: Dostawa produktów leczniczych Dispatch Date: 2026-08-05 Publish Date: 2026-08-06 Submission Date: 2026-09-07
Documents
Tender Notice